Literature DB >> 18839312

Control of growth factor networks by heparan sulfate proteoglycans.

Kimberly Forsten-Williams1, Chia Lin Chu, Michael Fannon, Jo Ann Buczek-Thomas, Matthew A Nugent.   

Abstract

Growth factor binding to transmembrane protein receptors is generally understood to initiate cell signaling. Receptor binding of heparin-binding growth factors (HB-GFs), such as fibroblast growth factor-2 (FGF-2), is regulated by interactions with heparan sulfate proteoglycans. While there is some specificity for binding to heparan sulfate, overlap in sites for different growth factors may allow for cross regulation. Here we demonstrate, using experiments and computer simulations, that the HB-GFs FGF-2 and heparin-binding EGF-like growth factor (HB-EGF) can cross regulate receptor binding of the other despite having unique receptors. The ability of HSPG to stabilize HB-GF receptor binding is critical for competing growth factors to modulate receptor binding with both enhanced and reduced binding possible depending on this stabilization process. HSPG density and affinity for HB-GF are also critical factors for HB-GF cross regulation. Simulations further reveal that HB-GF can regulate receptor binding of non-HB-GFs such as EGF even when the two proteins share no binding sites when other HB-GF are present within the network. Proliferation studies demonstrate potentiation of HB-EGF-induced growth by FGF-2 indicating that competition networks can alter biological response. Exogenous manipulation of cellular responses to growth factors in complex living systems will require understanding the HSPG-controlled network.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839312      PMCID: PMC2606109          DOI: 10.1007/s10439-008-9575-z

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  39 in total

Review 1.  The EGF receptor family: spearheading a merger of signaling and therapeutics.

Authors:  Erez M Bublil; Yosef Yarden
Journal:  Curr Opin Cell Biol       Date:  2007-02-20       Impact factor: 8.382

2.  Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.

Authors:  Bart S Hendriks; Lee K Opresko; H Steven Wiley; Douglas Lauffenburger
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

3.  Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.

Authors:  M Fannon; K E Forsten; M A Nugent
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

4.  Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans.

Authors:  G V Sperinde; M A Nugent
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

5.  Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.

Authors:  Niva Shraga-Heled; Ofra Kessler; Claudia Prahst; Jens Kroll; Hellmut Augustin; Gera Neufeld
Journal:  FASEB J       Date:  2006-12-21       Impact factor: 5.191

6.  Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts.

Authors:  J M Haugh; A C Huang; H S Wiley; A Wells; D A Lauffenburger
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Ceres C Chua; Nader Rahimi; Kimberly Forsten-Williams; Matthew A Nugent
Journal:  Circ Res       Date:  2003-12-18       Impact factor: 17.367

8.  pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release.

Authors:  Adrienne L Goerges; Matthew A Nugent
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

9.  Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo.

Authors:  Yufeng Zhang; Jianyi Li; Chohreh Partovian; Frank W Sellke; Michael Simons
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-01-23       Impact factor: 4.733

10.  Dimerization of VEGF receptors and implications for signal transduction: a computational study.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Biophys Chem       Date:  2007-03-24       Impact factor: 2.352

View more
  29 in total

1.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 2.  On, around, and through: neutrophil-endothelial interactions in innate immunity.

Authors:  Eric P Schmidt; Warren L Lee; Rachel L Zemans; Cory Yamashita; Gregory P Downey
Journal:  Physiology (Bethesda)       Date:  2011-10

3.  Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma?

Authors:  Rosa M Pascale; Diego F Calvisi; Francesco Feo
Journal:  Transl Gastroenterol Hepatol       Date:  2016-05-18

Review 4.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

Review 5.  Growth factor delivery strategies for rotator cuff repair and regeneration.

Authors:  Anupama Prabhath; Varadraj N Vernekar; Enid Sanchez; Cato T Laurencin
Journal:  Int J Pharm       Date:  2018-01-06       Impact factor: 5.875

Review 6.  Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.

Authors:  Sunil Rangarajan; Jillian R Richter; Robert P Richter; Shyam K Bandari; Kaushlendra Tripathi; Israel Vlodavsky; Ralph D Sanderson
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 7.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

Review 8.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

9.  A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.

Authors:  Satoshi Yamaji; Jun Saegusa; Katsuaki Ieguchi; Masaaki Fujita; Seiji Mori; Yoko K Takada; Yoshikazu Takada
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

10.  Endothelial cell capture of heparin-binding growth factors under flow.

Authors:  Bing Zhao; Changjiang Zhang; Kimberly Forsten-Williams; Jun Zhang; Michael Fannon
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.